KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (APLT)

CUSIP: 03828A101

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+2,012,961
Put/Call ratio
73%
SEC-reported price per share
$0.86
Number of holders
116
Value change
-$63,025,089
Number of buys
76
Open additional details 1 more signal available
Number of sells
71
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
143,223,667

Security key

03828A101

Report period

Q4 2024

Institutions

116

Top holders

10

Ownership snapshot

Top reported holders of APLT - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F Highest disclosed value: $89,655,696 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. has the largest disclosed position value at $89.66M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Disclosed position value Top 5
Janus Henderson Group Ltd. $89.66M
MORGAN STANLEY $84.19M
Venrock Adviser, LLC $83.51M
PERCEPTIVE ADVISORS LLC $68.04M
FRANKLIN TEMPLETON INC $60.46M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$89,655,696
10,541,528 shares
— 30 Sep 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$84,188,506
9,904,530 shares
— 30 Sep 2024
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$83,512,500
9,825,000 shares
— 30 Sep 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$68,042,500
8,005,000 shares
— 30 Sep 2024
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$60,460,090
6,800,910 shares
— 30 Sep 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$59,012,943
6,942,699 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
116
Shares
115,065,005
Rows available
116
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
125
Q4 2024 holders
116
Holder diff
-9
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .